Elorde, Reneboy .

HRN: 28-93-23  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2026
CEFTAZIDIME 1GM (VIAL)
04/30/2026
05/07/2026
IV
2G
Q8H
IMMUNOCOMPROMISED STATE, PNEUMONIA
Checking Initial Appropriateness 
05/06/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/06/2026
05/13/2026
IV
750mg
Q24h
Febrile Neutropenia
Checking Initial Appropriateness 
05/06/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/06/2026
05/13/2026
TIV
900mg
OD
Febrile Neutropenia
Checking Initial Appropriateness 
05/06/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
05/06/2026
05/13/2026
TIV
400mg
OD
Immunocompromised State Pneumonia
Checking Initial Appropriateness 
05/13/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
05/13/2026
05/19/2026
IV
400mg
OD
Immunocompromised State Pneumonia
Checking Initial Appropriateness 
05/13/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/13/2026
05/19/2026
IV
900mg
OD
Febrile Neutropenia
Checking Initial Appropriateness 
05/13/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/13/2026
05/19/2026
IV
750mg
OD
Febrile Neutropenia
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: